Rapid Micro Biosystems

Rapid Micro Biosystems is a life sciences technology company based in Lowell, Massachusetts, with additional locations in Switzerland, Germany, and the Netherlands. The company specializes in providing technology and products that support biomanufacturing, focusing on the rapid detection of microbial contamination in pharmaceuticals, biologics, medical devices, and personal care products. Their goal is to enhance quality control processes and improve patient outcomes. The flagship product, the Growth Direct System, automates traditional microbiology testing methods, facilitating efficient manufacturing and the safe release of healthcare products. This system is utilized for environmental monitoring, water testing, and bioburden testing, allowing for quicker contamination detection and improved quality control. By automating manual processes, the Growth Direct System reduces errors and enhances data integrity, ultimately accelerating production timelines. Rapid Micro Biosystems has partnered with Merck KGaA's Life Science business, granting MilliporeSigma co-exclusive rights to sell the Growth Direct systems and related consumables globally. The company is committed to being a trusted partner in quality control microbiology automation, helping manufacturers produce better products and improve patient outcomes.